OKRA.ai, a company providing advanced AI solutions for pharmaceutical and life sciences executives, today announces a collaboration with the AWS for Health initiative from Amazon Web Services (AWS) to help rapidly up-skill pharmaceutical companies that are looking to harness technology to engage with physicians and lower the costs of commercializing new treatments.
Loubna Bouarfa our CEO is interviewed by Euronews and describes her vision of what our health could look like in the future with Artificial Intelligence.
"Working with OKRA to co-develop tools for our field teams has been really satisfying, it has been like working with a trusted partner, open and honest discussion and ability to challenge each other leading to a product that met, and surpassed expectation."Neil Copping - Associate Director Data and Field Team Design - BMS
"OKRA is the only AI company in my experience to have delivered tangible value to the pharma industry."Sreeram Ramagopalan - Global Head Real World Data, Roche
"The team is superb, very collaborative and willing to flex their approach to meet our needs. OKRA helped us to uncover actionable insights."Ahmed Sidat - Head of Digital and Multichannel - Janssen Pharmaceuticals
"In my view, OKRA can help take Pharma to a new level when it comes to truly benefitting from AI in their commercial practices, and it helps that they’re a great team to work with too!"Colin Williams - Global Product Lead, Veeva Rep Channels, GSK
How can the EU embrace the opportunities represented by human-centred AI? Discover how to transition towards the successful development and use of AI in Europe, in a way that citizens will trust.
Do you want to learn more?
Leave your email here and we will contact you.
For any other requests including press and speaking opportunities, please email email@example.com